Ligand Pharmaceuticals
LGND
#2813
Rank
NZ$10.53 B
Marketcap
NZ$526.81
Share price
-2.71%
Change (1 day)
43.99%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2026 (TTM): NZ$0.10 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.25 Billion. In 2025 the company made an earning of NZ$0.29 Billion, an increase over its 2024 earnings that were of NZ$10.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) NZ$0.10 B-64.51%
2025 NZ$0.29 B2848.57%
2024 NZ$10.06 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.12 B296.42%
2020 NZ$30.6 M-97.97%
2019 NZ$1.50 B275.62%
2018 NZ$0.40 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$79.85 M55.41%
2015 NZ$51.38 M36.87%
2014 NZ$37.54 M29.59%
2013 NZ$28.97 M1309.35%
2012 NZ$2.05 M-43.97%
2011 NZ$3.66 M-113.19%
2010 -NZ$27.82 Million59.86%
2009 -NZ$17.41 Million-61.33%
2008 -NZ$45 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$90.51 Million81.27%
2005 -NZ$49.94 Million
2003 -NZ$34.77 Million-20.6%
2002 -NZ$43.78 Million4.38%
2001 -NZ$41.95 Million-48.83%
2000 -NZ$81.96 Million-19.74%
1999 -NZ$0.11 Billion-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$55.65 Million-5.83%
1996 -NZ$59.1 Million136.23%
1995 -NZ$25.02 Million-33.97%
1994 -NZ$37.89 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.93 B 30,636.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
NZ$12.63 B 11,340.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$63.02 B 56,983.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
NZ$20.03 B 18,045.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
-NZ$0.34 Billion-407.02%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.18 B 10,937.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$20.54 B 18,504.80%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$12.96 B 11,646.16%๐Ÿ‡ฌ๐Ÿ‡ง UK
Spectrum Pharmaceuticals
SPPI
-NZ$0.12 Billion-201.60%๐Ÿ‡บ๐Ÿ‡ธ USA